Artificial intelligence in cancer pathology: Applications, challenges, and future directions.

IF 3.1 4区 医学 Q2 PATHOLOGY
Cytojournal Pub Date : 2025-04-19 eCollection Date: 2025-01-01 DOI:10.25259/Cytojournal_272_2024
Jiule Wang, Teng Wang, Rui Han, Dongmei Shi, Biao Chen
{"title":"Artificial intelligence in cancer pathology: Applications, challenges, and future directions.","authors":"Jiule Wang, Teng Wang, Rui Han, Dongmei Shi, Biao Chen","doi":"10.25259/Cytojournal_272_2024","DOIUrl":null,"url":null,"abstract":"<p><p>The application of artificial intelligence (AI) in cancer pathology has shown significant potential to enhance diagnostic accuracy, streamline workflows, and support precision oncology. This review examines the current applications of AI across various cancer types, including breast, lung, prostate, and colorectal cancer, where AI aids in tissue classification, mutation detection, and prognostic predictions. The key technologies driving these advancements include machine learning, deep learning, and computer vision, which enable automated analysis of histopathological images and multi-modal data integration. Despite these promising developments, challenges persist, including ensuring data privacy, improving model interpretability, and meeting regulatory standards. Furthermore, this review explores future directions in AI-driven cancer pathology, including real-time diagnostics, explainable AI, and global accessibility, emphasizing the importance of collaboration between AI and pathologists. Addressing these challenges and leveraging AI's full potential could lead to a more efficient, equitable, and personalized approach to cancer care.</p>","PeriodicalId":49082,"journal":{"name":"Cytojournal","volume":"22 ","pages":"45"},"PeriodicalIF":3.1000,"publicationDate":"2025-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12134795/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cytojournal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.25259/Cytojournal_272_2024","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The application of artificial intelligence (AI) in cancer pathology has shown significant potential to enhance diagnostic accuracy, streamline workflows, and support precision oncology. This review examines the current applications of AI across various cancer types, including breast, lung, prostate, and colorectal cancer, where AI aids in tissue classification, mutation detection, and prognostic predictions. The key technologies driving these advancements include machine learning, deep learning, and computer vision, which enable automated analysis of histopathological images and multi-modal data integration. Despite these promising developments, challenges persist, including ensuring data privacy, improving model interpretability, and meeting regulatory standards. Furthermore, this review explores future directions in AI-driven cancer pathology, including real-time diagnostics, explainable AI, and global accessibility, emphasizing the importance of collaboration between AI and pathologists. Addressing these challenges and leveraging AI's full potential could lead to a more efficient, equitable, and personalized approach to cancer care.

Abstract Image

Abstract Image

Abstract Image

人工智能在癌症病理学中的应用、挑战和未来方向。
人工智能(AI)在癌症病理学中的应用已经显示出提高诊断准确性、简化工作流程和支持精确肿瘤学的巨大潜力。本文综述了目前人工智能在各种癌症类型中的应用,包括乳腺癌、肺癌、前列腺癌和结直肠癌,人工智能在组织分类、突变检测和预后预测方面的帮助。推动这些进步的关键技术包括机器学习、深度学习和计算机视觉,这些技术可以实现组织病理图像的自动分析和多模态数据集成。尽管有这些有希望的发展,挑战仍然存在,包括确保数据隐私、提高模型可解释性和满足监管标准。此外,本文还探讨了人工智能驱动的癌症病理学的未来发展方向,包括实时诊断、可解释的人工智能和全球可及性,强调了人工智能与病理学家之间合作的重要性。应对这些挑战并充分利用人工智能的潜力,可以为癌症治疗带来更有效、更公平和更个性化的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cytojournal
Cytojournal PATHOLOGY-
CiteScore
2.20
自引率
42.10%
发文量
56
审稿时长
>12 weeks
期刊介绍: The CytoJournal is an open-access peer-reviewed journal committed to publishing high-quality articles in the field of Diagnostic Cytopathology including Molecular aspects. The journal is owned by the Cytopathology Foundation and published by the Scientific Scholar.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信